Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Longlong Shao

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Thoracic Disease|December 23, 2017
Clinical analyses on salvage lymphadenectomy through cervical incision for patients with cervical and cervicothoracic recurrences after esophagectomyDong Lin, Shujun Jiang, Longfei Ma, et al.
Journal of Thoracic Disease|December 13, 2023
Safety of omitting nasogastric decompression after esophagectomy: a propensity score-matched studyRan Guo, Longlong Shao, Bin Li, et al.
Journal of Thoracic Disease|July 13, 2018
Three-field versus two-field lymph node dissection for thoracic esophageal squamous cell carcinoma: a propensity score-matched comparisonLonglong Shao, Ting Ye, Longfei Ma, et al.
Journal of Thoracic Disease|March 10, 2017
Results of neoadjuvant therapy followed by esophagectomy for patients with locally advanced thoracic esophageal squamous cell carcinomaDong Lin, Longfei Ma, Ting Ye, et al.
Surgical Endoscopy|September 17, 2017
Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1 esophageal cancer? A propensity score-based analysisShengfei Wang, Yangle Huang, Juntao Xie, et al.
International Journal of Cancer|December 17, 2024
Tislelizumab combined with nab-paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two-cohort, phase 2 trialJie Wang, Bin Li, Yawei Zhang, et al.
Journal of Thoracic Disease|May 25, 2026
Segmentectomy achieves comparable survival outcomes compared to lobectomy in peripheral ≤3 cm non-small cell lung cancer with occult lymph node metastasesYuting Chen, Jie Wang, Xusheng Ding, et al.
Oncotargets and Therapy|August 26, 2014
Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinomaHaichuan Hu, Yunjian Pan, Yuan Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 11, 2020
Esophagectomy With Three-Field Versus Two-Field Lymphadenectomy for Middle and Lower Thoracic Esophageal Cancer: Long-Term Outcomes of a Randomized Clinical TrialBin Li, Yawei Zhang, Longsheng Miao, et al.
Signal Transduction and Targeted Therapy|July 16, 2025
Comprehensive genomic and transcriptomic analyses reveal prognostic stratification for esophageal squamous cell carcinomaJian Gao, Qiming Wang, Fangqiu Fu, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Thoracic Disease|December 23, 2017
Clinical analyses on salvage lymphadenectomy through cervical incision for patients with cervical and cervicothoracic recurrences after esophagectomyDong Lin, Shujun Jiang, Longfei Ma, et al.
Journal of Thoracic Disease|December 13, 2023
Safety of omitting nasogastric decompression after esophagectomy: a propensity score-matched studyRan Guo, Longlong Shao, Bin Li, et al.
Journal of Thoracic Disease|July 13, 2018
Three-field versus two-field lymph node dissection for thoracic esophageal squamous cell carcinoma: a propensity score-matched comparisonLonglong Shao, Ting Ye, Longfei Ma, et al.
Journal of Thoracic Disease|March 10, 2017
Results of neoadjuvant therapy followed by esophagectomy for patients with locally advanced thoracic esophageal squamous cell carcinomaDong Lin, Longfei Ma, Ting Ye, et al.
Surgical Endoscopy|September 17, 2017
Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1 esophageal cancer? A propensity score-based analysisShengfei Wang, Yangle Huang, Juntao Xie, et al.
International Journal of Cancer|December 17, 2024
Tislelizumab combined with nab-paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two-cohort, phase 2 trialJie Wang, Bin Li, Yawei Zhang, et al.
Journal of Thoracic Disease|May 25, 2026
Segmentectomy achieves comparable survival outcomes compared to lobectomy in peripheral ≤3 cm non-small cell lung cancer with occult lymph node metastasesYuting Chen, Jie Wang, Xusheng Ding, et al.
Oncotargets and Therapy|August 26, 2014
Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinomaHaichuan Hu, Yunjian Pan, Yuan Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 11, 2020
Esophagectomy With Three-Field Versus Two-Field Lymphadenectomy for Middle and Lower Thoracic Esophageal Cancer: Long-Term Outcomes of a Randomized Clinical TrialBin Li, Yawei Zhang, Longsheng Miao, et al.
Signal Transduction and Targeted Therapy|July 16, 2025
Comprehensive genomic and transcriptomic analyses reveal prognostic stratification for esophageal squamous cell carcinomaJian Gao, Qiming Wang, Fangqiu Fu, et al.
Pageof 3